CTKB Cytek Biosciences
- 5.140
- -0.100-1.91%
- 5.140
- 0.0000.00%
Cytek Biosciences News
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8
Cytek Biosciences Analyst Ratings
Cytek Biosciences: Hold Rating Amidst Mixed Performance and Cautious U.S. Market Outlook
TD Cowen Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $12
Cytek Biosciences: Poised for Turnaround Despite Q2 Setbacks, Analyst Maintains Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Cytek Biosciences Analyst Ratings
Cytek Biosciences (CTKB) Receives a Buy From Piper Sandler
Cytek Biosciences Analyst Ratings
Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)
Cytek Biosciences (CTKB) Gets a Buy From Piper Sandler
Cytek Biosciences: A Strong Buy Rating Backed by Solid Financials and Strategic Growth Initiatives
TD Cowen Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)
Piper Sandler Keeps Their Buy Rating on Cytek Biosciences (CTKB)
Stephens & Co. Initiates Coverage On Cytek Biosciences With Overweight Rating, Announces Price Target of $9
Cytek Biosciences Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Cytek Biosciences (CTKB), DENTSPLY SIRONA (XRAY)
Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7
Cytek Biosciences Analyst Ratings
Analysis
Price Target
No Data
No Data